In individuals who have undergone knee or hip replacement surgery, clinicians are noticing increasing numbers of chronic bone infections linked to a bacterial strain commonly found on the skin.
WuXi fallout reverberates; Pharma’s top R&D spenders; Lilly teams up with Amazon; Historic NASH approval; and more
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit